Articles: Schizophrenia

Niemann-Pick Disease Type C – Example of an Inborn Error of Metabolism Producing Psychiatric Manifestations
Olivier Bonnot
European Psychiatric Review, 2011;4(2):84-88
Psychomotor Psychoses – The Enigmatic Catatonic Phenotype
Willem MA Verhoeven, Frank MMA van der Heijden, Bruno Pfuhlmann, Gerald Stöber
European Psychiatric Review, 2011;4(2):78-83
Trauma and Stigma as Defeating Experiences Over the Life Course Interacting with Genetic Liability in Schizophrenia
Catherine van Zelst
European Psychiatric Review, 2010;3(1):35-38
Data Collection and Conduction of Pharmacoeconomic Studies in Greece
Maria Geitona, Loukas Xaplanteris
European Psychiatric Review, 2010;3(1):21-25
Genetic Strategies for Schizophrenia
Florence Thibaut
European Psychiatric Review, 2010;3(1):30-34
The Leonhardean Classification of Endogenous Psychoses – Predictive Validity at Two Subsequent Follow-ups in a Long-term Prospective Study (Budapest 2000)
Bertalan Pethö
European Psychiatric Review, 2010;3(1):39-43
Patterns of Mental Health Service Use and Unmet Needs for Care in Individuals with Schizophrenia in the US
Ramin Mojtabai, Laura Fochtmann, Roman Kotov, Su-Wei Chang, Thomas J Craig, Evelyn Bromet
US Psychiatry, 2010;3:53-58
Exploring the Prodrome to First Psychosis
Barbara Walsh, Thomas H McGlashan
US Psychiatry, 2009;2(1):45-47
The Genetics of Schizophrenia—Is This a Time for Revising the ‘Method’?
Theodor Rais
US Psychiatry, 2009;2(1):41-44
Brain Structure Findings in Schizophrenia – Implications for Aetiology
Ingrid Agartz
European Psychiatric Review, 2009;2(2):16-20
DAOA – An Update on Its Biology and Its Impact on Schizophrenia
Carolin Opgen-Rhein, Michael Dettling
European Psychiatric Review, 2009;2(2):11-15
Cavum Septum Pellucidum and Adhesio Interthalamica Abnormalities in Schizophrenia
José Alexandre de Souza Crippa, Geraldo Busatto Filho, Clarissa Trzesniak
European Psychiatric Review, 2009;2(2):7-10
The Significance of Cognitive Functioning, Physical Health and Early Non-response in Schizophrenia
Cindy Lee, Umair Shafique, Jo C Neill, Philip D Harvey, John Newcomer, Marc De Hert, Stefan Leucht, Shitij Kapur
European Psychiatric Review, 2009;2(1):24-38
Antipsychotics for Schizophrenia – Changing Minds, Minding Change
Nikolaos Christodoulou, Vassilis Kontaxakis
European Psychiatric Review, 2009;2(1):39-41
Influence of Genetic and Modifiable Factors on Metabolic Consequences of Antipsychotic Drug Treatment
Gavin P Reynolds, Olga O Yevtushenko, Stephen J Cooper
European Psychiatric Review, 2008;1(2):67-69
Computerised Assessment of Visuo-spatial Cognition in Schizophrenia – An Exploratory Meta-analysis of CANTAB Findings
Emmanuel Stip, Laurent Lecardeur, Amir Ali Sepehry
European Psychiatric Review, 2008;1(2):48-54
Sertindole in Clinical Practice
Chris Hawley
European Psychiatric Review, 2008;1(2):44-47
Pre-clinical Profiling of Antipsychotics – New Data and Implications for Clinical Outcome
Bernd Galhoffer
European Psychiatric Review, 2008;1(2):38-43
Why Are Children and Adolescents with 22q11.2 Deletion Syndrome at High Risk of Developing Schizophrenia?
Stephan Eliez, Martin Debbané
European Psychiatric Review, 2008;1(1):51-55
Current Perspectives on Augmentation of Clozapine Partial Responders with Other Antipsychotics
Rajaprabhakaran Rajarethinam, Nitin Rajhans, Humera Athar, Albert Pizzuti, Beth Ann Brooks
US Psychiatry, 2007:40-42
Tryptophan Metabolism as a New Target for the Treatment of Schizophrenia
Gregory F Oxenkrug
US Psychiatry, 2007:38-39
close

This content is copyright protected

However, if you would like to share the information on this webpage, you may use the headline and link below:

Articles: Schizophrenia

Read more: Articles: Schizophrenia